Cardiac Dimensions Lands $20,000,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=196228a0-d557-447c-b768-46c8a171d6e9
Date
4/17/2014
Company Name
Cardiac Dimensions
Mailing Address
5540 Lake Washington Blvd. NE Kirkland, WA 98033 USA
Company Description
Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of congestive heart failure (CHF) and related conditions.
Website
http://www.cardiacdimensions.com
Transaction Type
Venture Equity
Transaction Amount
$20,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds from the financing will be used to initiate a multi-national, blinded, randomized clinical trial, REDUCE-FMR, involving up to 20 hospitals, with the objective to firmly establish CARILLON as the gold standard therapy in the treatment of functional mitral regurgitation (FMR).
M&A Terms
Venture Investor
Venture Investor